Switch to:

Ratios

vs
industry
vs
history
P/E(ttm) 24.37
IBB's P/E(ttm) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IBB: 24.37 )
Ranked among companies with meaningful P/E(ttm) only.
IBB' s P/E(ttm) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 24.37
Current: 24.37
0
24.37
PE(NRI) 24.37
IBB's PE(NRI) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IBB: 24.37 )
Ranked among companies with meaningful PE(NRI) only.
IBB' s PE(NRI) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 24.37
Current: 24.37
0
24.37

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.05
IBB's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IBB: 0.05 )
Ranked among companies with meaningful Dividend Yield only.
IBB' s Dividend Yield Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 0.05
Current: 0.05
0
0.05
Yield on cost (5-Year) 0.05
IBB's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IBB: 0.05 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
IBB' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 0.05
Current: 0.05
0
0.05

More Statistics

Short Percentage of Float0.00%
52-Week Range $244.04 - 397.96
Shares Outstanding(Mil)24950000.00
» More Articles for IBB

Headlines

Articles On GuruFocus.com
Tom Gayner Discusses His Evolution as an Investor Feb 13 2016 
Eaton Vance: 4 Reasons to Take a Good Look Feb 13 2016 
Cubic Corp. Insider Purchases 2,000 Shares Feb 13 2016 
Bill Ackman Reports Taking 19% Stake in Euro Food Company Nomad in December Feb 12 2016 
Mohnish Pabrai Cuts Losses With Struggling Steelmaker Posco Feb 12 2016 
Daniel Loeb Buys Axalta, Morgan Stanley, Chubb Feb 12 2016 
Chubb Merger With ACE Creates Strong Insurance Firm Feb 12 2016 
Baron Emerging Market Fund 4th Quarter Letter Feb 12 2016 
Brexit Threat - Market Commentary From Causeway Capital Feb 12 2016 
Keeley Funds Comments on Marriott Vacations Worldwide Corp Feb 12 2016 

More From Other Websites
Stock Market Video Analysis 2/12/16 Feb 12 2016
Don't bail on biotech: Pro Feb 12 2016
A serious warning for the Nasdaq: Analyst Feb 11 2016
Morgan Stanley is Wrong: This Biotech is Ready to Explode Higher Feb 11 2016
Relypsa: This Biotech Just Released Stunning Data Feb 10 2016
Biotech ETFs Slide as Stocks Report Mixed Q4 Results Feb 09 2016
Rebound For Big Biotech ETF Will Require Some Patience Feb 09 2016
Be careful buying beatdown biotechs: Pro Feb 09 2016
#1 Rated Biotech Analyst on the Sell-Off Feb 08 2016
The market's brightest stars are losing momentum Feb 08 2016
Avoid biotech until elections? Analyst's view Feb 08 2016
Tough end to the week for tech Feb 05 2016
Biotech stocks too risky? Feb 05 2016
Gilead Sciences: Why Slowing Hep-C Sales Don't Matter Feb 05 2016
Shkreli's attorney: He's been unfairly vilified Feb 04 2016
It’s Time to Buy This Biotech Gem Feb 04 2016
TickerTags Data Shows Drug Price Debate Still Trending Feb 03 2016
Michael Kors -- On Its Way to $60? Feb 03 2016
Dividend Growth ‘Bubble’ To Continue But For How Long? Feb 03 2016
An overview on the biotech sector: Pro Feb 02 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK